id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-2246-0003,FDA,FDA-2020-N-2246,Fee Rates Under the Over-the-Counter  Monograph Drug User Fee Program for Fiscal Year 2021,Notice,Announcement,2021-03-26T04:00:00Z,2021,3,2021-03-26T04:00:00Z,,2021-03-26T15:04:11Z,2021-06361,0,0,0900006484a7e050
FDA-2020-N-2246-0002,FDA,FDA-2020-N-2246,Withdrawal of FDA Notice Regarding Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021,Notice,Withdrawal,2021-01-06T05:00:00Z,2021,1,2021-01-06T05:00:00Z,,2021-01-06T14:57:27Z,2021-00030,0,0,09000064849e08bb
FDA-2020-N-2246-0001,FDA,FDA-2020-N-2246,Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021,Notice,Announcement,2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T17:03:53Z,2020-28714,0,0,09000064849cfd28